Ak
Akero Therapeutics Inc
AKRO · NASDAQ22.59
Ak
22.59
USD-2.29-9.20%Balance Sheet
Total Assets
138.12M
Liabilities And Stockholders Equity
138.12M
Income Statement
Total Revenue
-
Cost Of Revenue
-
Gross Profit
-
Total Operating Expenses
45.65M
Operating Income
-45.65M
Income Before Tax
-43.76M
Net Income After Taxes
-
Net Income Before Extraordinary Items
-
Net Income
-43.76M
Net Income Applicable To Common Shares
-43.76M
Diluted Net Income
-43.76M
Diluted Weighted Average Shares
28.34
Diluted EPS Excluding Extraordinary Items
-
Diluted Normalized EPS
-1.54
EBIT
-45.65M
Cash Flow
Total Cash From Operating Activities
-35.63M
Total Cash Flows From Investing Activities
-71.51M
Total Cash From Financing Activities
95.99M
Exchange Rate Changes
-
Change In Cash
-11.15M
Free Cash Flow
-35.63M
What are you waiting for?Start making profit today
©
2025
All rights reserved